House Erbitux Probe Widens To Firms That Considered ImClone Partnership
The House Energy & Commerce Committee is widening its Erbitux investigation to include several companies who considered partnering with ImClone on the colorectal cancer drug
The House Energy & Commerce Committee is widening its Erbitux investigation to include several companies who considered partnering with ImClone on the colorectal cancer drug